NEW YORK, Feb. 27, 2025 /PRNewswire/ — Woolsey Pharmaceuticals today announced the successful completion of an extension to its Series B Preferred financing round by existing investors. “We are immensely grateful for the continued support of our investors and remain steadfast and…
